Evento

Effect of estrogen estrone on uterine and adipose tissue under obesity

Valle, María Ivone ; Cepeda, Sabrina Belén Icon; Cutini, Pablo Hernan Icon; Sandoval, Marisa Julia ; Massheimer, Virginia Laura Icon

Otros responsables

Fecha

2023

Editorial

Fundación Revista Medicina

Revista

Título del libro

Nombre del evento

Reunión Anual de Sociedades de Biociencias 2023; LXVIII Annual Meeting of Sociedad Argentina de Investigación Clínica (SAIC); XXV Annual Conferences of Sociedad Argentina de Biología (SAB); LV Annual Meeting of Asociación Argentina de Farmacología Experimental (AAFE); VIII Regional Scientific Meeting of Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio (AACYTA)

Fecha del evento

2023-11-15

Institución organizadora

Sociedad argentina de investigación clínica
Sociedad argentina de inmunología
Asociación argentina de farmacología experimental
Asociación argentina de ciencia y tecnología de animales de laboratorio

ISSN

1669-9106

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Congreso

Clasificación temática

Resumen

Previously we reported that, estrone (E1) counteracts uterine oxidative stress induced by an inflammatory environment. In this work, using an experimental model of obesity, the direct action of E1 on uterus (Ut) and adipose tissue (AT) was evaluated. In order to rule out the influence of the hormonal impact during estrous cycle, animals were bilaterally ovariectomized (OVX). Rats were fed with high-fat diet (OVX-Ob) for 10 weeks. After isolation, Ut and retroperitoneal AT explants were in vitro expose to 10 nM E1. Histological analysis of Ut explants (H&E staining) showed that in non-OVX rats exhibited a thicker endometrial layer with great amount of uterine glands compared to uterus sections from OVX rats, verifying the absence of estrous cycles in OVX group. The serum biochemical evaluation showed that, Ob rats exhibited higher levels of serum H2O2; TBARS, and leptin than non-obese (8; 65; 122% above non-Ob, respectively, p< 0.05), profile compatible with obesity. After E1 treatment (4h), Ut slices exhibited an enhancement in nitric oxide synthesis (33% above control P<0.001) and reduction in ROS production (30% below control, P<0.01). To assess whether the effect of E1 on H2O2 generation depends on its ability to enhance NO synthesis, an irreversible NOS inhibitor (L-NAME) was employed. In the presence of L-NAME, the reduction on ROS production elicited by E1 was blocked, suggesting NO dependence. Indeed, in OVX-Ob rats the steroid treatment stimulates uterus angiogenesis. Concomitantly, on AT explants isolated from OVX-Ob rats, E1 prompted an antioxidant action. E1 reduced H202 secretion (2375±263 vs 1978±241 nmol/g AT, C vs E1 p<0.05), and TBARS released (502±195 vs 353±30 nmol/g AT, C vs E1 p<0.05). Indeed, a 14% reduction on leptin secretion was also detected (p<0.05). The results presented evidenced that adipose tissue is targeted of E1 action, and that under obesity the hormone exerts a protective action on Ut and AT reducing oxidative stress.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa